Trident Texofab Closes Trading Window for Insider Trading Rules

Trident Texofab Ltd has announced the closure of its trading window for dealing in the company's securities, effective July 01, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will reopen 48 hours after the conclusion of the Board of Directors' meeting, which is scheduled to approve the Un-Audited Standalone Financial Results for the quarter ended June 30, 2026. The exact date of the board meeting will be communicated separately. This measure is standard practice to prevent potential insider trading ahead of financial result announcements.